Medicare Patients Unable To Get Alzheimer's Drug Sparks Backlash 0 17.06.2024 17:31 NewsWeek.com Although the FDA has determined lecanemab's benefits outweigh its risks in treating Alzheimer's, the CMS is pressing for more data on its efficacy and safety. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
